Cargando…

Iron deficiency impacts prognosis but less exercise capacity in heart failure with preserved ejection fraction

AIMS: Whether and how iron deficiency (ID) impacts patients with heart failure (HF) with preserved ejection fraction (HFpEF) remain unclear. The aim of our study was to investigate the impact of ID on functional status, exercise capacity, and prognosis in HFpEF. METHODS AND RESULTS: The study popula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barandiarán Aizpurua, Arantxa, Sanders‐van Wijk, Sandra, Brunner‐La Rocca, Hans‐Peter, Henkens, Michiel T.H.M., Weerts, Jerremy, Spanjers, Mireille H.A., Knackstedt, Christian, van Empel, Vanessa P.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006701/ https://www.ncbi.nlm.nih.gov/pubmed/33522131 http://dx.doi.org/10.1002/ehf2.13204

Ejemplares similares

The HFA‐PEFF and H(2)FPEF scores largely disagree in classifying patients with suspected heart failure with preserved ejection fraction
por: Sanders‐van Wijk, Sandra, et al.
Publicado: (2020)

The Role of Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction
por: Weerts, Jerremy, et al.
Publicado: (2022)

The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fraction
por: Weerts, Jerremy, et al.
Publicado: (2021)

Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review
por: Henkens, Michiel T.H.M., et al.
Publicado: (2020)

Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fraction
por: Weerts, J, et al.
Publicado: (2023)

Webtool to enhance the accuracy of diagnostic algorithms for HFpEF: a prospective cross‐over study
por: Weerts, Jerremy, et al.
Publicado: (2023)

Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registry
por: Henkens, Michiel T.H.M., et al.
Publicado: (2022)

Association of left ventricular strain–volume loop characteristics with adverse events in patients with heart failure with preserved ejection fraction
por: Kerstens, Thijs P, et al.
Publicado: (2023)

A global longitudinal strain cut‐off value to predict adverse outcomes in individuals with a normal ejection fraction
por: Verdonschot, Job A.J., et al.
Publicado: (2021)

Association between phonocardiography and echocardiography in heart failure patients with preserved ejection fraction
por: Luo, Hongxing, et al.
Publicado: (2022)

Increased myocardial stiffness more than impaired relaxation function limits cardiac performance during exercise in heart failure with preserved ejection fraction: a virtual patient study
por: van Loon, Tim, et al.
Publicado: (2020)

Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients
por: Raafs, Anne G., et al.
Publicado: (2022)

The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy
por: Raafs, Anne G., et al.
Publicado: (2021)

Natriuretic peptides for the detection of diastolic dysfunction and heart failure with preserved ejection fraction—a systematic review and meta-analysis
por: Remmelzwaal, Sharon, et al.
Publicado: (2020)

Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction
por: Uijl, Alicia, et al.
Publicado: (2021)

Epicardial Adipose Tissue and Outcome in Heart Failure With Mid-Range and Preserved Ejection Fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double‐blind, randomized, placebo‐controlled clinical trial
por: Hazebroek, Mark R., et al.
Publicado: (2021)

A graphical analysis of aspects contributing to the spreading of measurements of left ventricular function
por: Knackstedt, Christian, et al.
Publicado: (2023)

Ventricular tachyarrhythmia detection by implantable loop recording in patients with heart failure and preserved ejection fraction: the VIP‐HF study
por: van Veldhuisen, Dirk J., et al.
Publicado: (2020)

Biomarkers of Collagen Metabolism Are Associated with Left Ventricular Function and Prognosis in Dilated Cardiomyopathy: A Multi-Modal Study
por: Raafs, Anne G., et al.
Publicado: (2023)

Clinical profile and contemporary management of patients with heart failure with preserved ejection fraction: results from the CHECK-HF registry
por: Uijl, A., et al.
Publicado: (2021)

Hemodynamic Profile of Patients With Heart Failure and Preserved Ejection Fraction Vary by Age
por: Nanayakkara, Shane, et al.
Publicado: (2017)

Impact of airflow limitation in chronic heart failure
por: Bektas, S., et al.
Publicado: (2017)

Diagnostic and prognostic implications of heart failure with preserved ejection fraction scoring systems
por: Parcha, Vibhu, et al.
Publicado: (2021)

Impaired Myocardial Oxygen Availability Contributes to Abnormal Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: van Empel, Vanessa P. M., et al.
Publicado: (2014)

The clinical and prognostic value of late Gadolinium enhancement imaging in heart failure with mid-range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Interatrial Block Predicts Life‐Threatening Arrhythmias in Dilated Cardiomyopathy
por: Henkens, Michiel T. H. M., et al.
Publicado: (2022)

Prevalence and Incidence of Atrial Fibrillation in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: (Additive) Value of Implantable Loop Recorders
por: Gorter, Thomas M., et al.
Publicado: (2023)

Disagreement of ESC guidelines from 2016 and 2021 and HFA-PEFF and H2 FPEF scores in diagnosis of heart failure with preserved ejection fraction in atrial fibrillation patients
por: Gawalko, M, et al.
Publicado: (2023)

Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction
por: Dal Canto, Elisa, et al.
Publicado: (2020)

The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles
por: Henkens, Michiel T.H.M., et al.
Publicado: (2022)

The Cardiomyocyte in Heart Failure with Preserved Ejection Fraction—Victim of Its Environment?
por: Rocca, Angela, et al.
Publicado: (2022)

Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid‐range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

Heart failure with preserved, mid‐range, and reduced ejection fraction across health care settings: an observational study
por: de Boer, Annemarijn R., et al.
Publicado: (2021)

Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis
por: van den Berg, Maarten P, et al.
Publicado: (2019)

Epicardial fat in heart failure patients with mid‐range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2018)

Obesity, epicardial adipose tissue and left atrial cardiomyopathy in patients with heart failure with preserved ejection fraction: a cardiac MRI based study
por: Lobeek, M, et al.
Publicado: (2023)

Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment?
por: Peeters, J. M. P. W. U., et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0j57n3m8qvtsfpiun66odiiite